Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.160 | 6 | 151873899 | intron variant | G/A | snv | 0.26 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.882 | 0.160 | 6 | 151873899 | intron variant | G/A | snv | 0.26 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.882 | 0.160 | 6 | 151873899 | intron variant | G/A | snv | 0.26 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 6 | 151653287 | upstream gene variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||||
|
0.925 | 0.080 | 6 | 151653287 | upstream gene variant | C/T | snv | 0.16 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||||
|
1.000 | 6 | 151842613 | stop gained | C/T | snv |
|
0.700 | 0 | |||||||||||||
|
6 | 152094402 | missense variant | T/C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.080 | 6 | 152098779 | missense variant | T/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 6 | 152098779 | missense variant | T/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
6 | 152098782 | missense variant | C/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
6 | 152098785 | missense variant | T/G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 2 | 2013 | 2013 | ||||||||||
|
6 | 152011697 | missense variant | G/C | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2013 | 2014 | ||||||||||
|
6 | 152011697 | missense variant | G/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
0.882 | 0.080 | 6 | 152102770 | 3 prime UTR variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.882 | 0.080 | 6 | 152102770 | 3 prime UTR variant | T/A;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||||||
|
0.882 | 0.080 | 6 | 152102770 | 3 prime UTR variant | T/A;G | snv |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.882 | 0.080 | 6 | 152102770 | 3 prime UTR variant | T/A;G | snv |
|
0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
6 | 151718829 | intron variant | T/C | snv | 0.33 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
6 | 151711782 | intron variant | C/T | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
6 | 151756711 | intron variant | C/T | snv | 0.44 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||||
|
1.000 | 0.040 | 6 | 151878224 | intron variant | T/C | snv | 0.25 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
6 | 151759600 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2009 | 2009 | |||||||||||
|
1.000 | 6 | 152011740 | missense variant | G/A | snv |
|
0.800 | 0 | |||||||||||||
|
6 | 151754327 | intron variant | TT/-;T;TTT;TTTT;TTTTT;TTTTTTTT;TTTTTTTTTT;TTTTTTTTTTTTTTTTT | delins |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 6 | 151726887 | intron variant | C/T | snv | 0.32 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 |